[HTML][HTML] Optimization of secreted recombinant human epidermal growth factor production using pectate lyase B from Escherichia coli BL21 (DE3) by central composite …
Context: Human Epidermal Growth Factor (hEGF) is a potential therapeutic protein that has
been widely used as a healing agent for various chronic wounds. It induces the proliferation …
been widely used as a healing agent for various chronic wounds. It induces the proliferation …
[HTML][HTML] Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21 (DE3) by Central …
S Sriwidodo, T Subroto, IP Maksum… - Journal of Pharmacy …, 2019 - ncbi.nlm.nih.gov
Aims: Therefore, this study was conducted to optimize the induction time and medium
concentration for rhEGF extracellular secretion then followed by scale-up production …
concentration for rhEGF extracellular secretion then followed by scale-up production …
Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite …
S Sriwidodo, T Subroto, IP Maksum… - Journal of Pharmacy …, 2019 - europepmc.org
Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using
Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its …
Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its …
Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21 (DE3) by Central Composite …
S Sriwidodo, T Subroto, IP Maksum… - … of pharmacy & …, 2019 - pubmed.ncbi.nlm.nih.gov
Context Human Epidermal Growth Factor (hEGF) is a potential therapeutic protein that has
been widely used as a healing agent for various chronic wounds. It induces the proliferation …
been widely used as a healing agent for various chronic wounds. It induces the proliferation …
[PDF][PDF] Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21 (DE3) by Central …
S Sriwidodo, T Subroto, IP Maksum, N Wathoni… - 2019 - researchgate.net
Context: Human Epidermal Growth Factor (hEGF) is a potential therapeutic protein that has
been widely used as a healing agent for various chronic wounds. It induces the proliferation …
been widely used as a healing agent for various chronic wounds. It induces the proliferation …
Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21 (DE3) by Central Composite …
S Sriwidodo, T Subroto, IP Maksum… - … of Pharmacy & …, 2019 - search.ebscohost.com
Abstract Context: Human Epidermal Growth Factor (hEGF) is a potential therapeutic protein
that has been widely used as a healing agent for various chronic wounds. It induces the …
that has been widely used as a healing agent for various chronic wounds. It induces the …
Optimization of secreted recombinant human epidermal growth factor production using pectate lyase B from Escherichia coli BL21 (DE3) by central composite design …
S Sriwidodo, T Subroto, I Maksum… - … of Pharmacy and …, 2019 - search.proquest.com
Abstract Context: Human Epidermal Growth Factor (hEGF) is a potential therapeutic protein
that has been widely used as a healing agent for various chronic wounds. It induces the …
that has been widely used as a healing agent for various chronic wounds. It induces the …
Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite …
S Sriwidodo, T Subroto, IP Maksum… - Journal of Pharmacy …, 2019 - europepmc.org
Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using
Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its …
Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its …